Clinical trial
POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in PATIENTS With…
NCT02536378 · Silk Road Medical, Industry · Completed
Key facts
| NCT number | NCT02536378 |
|---|---|
| Title | POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE |
| Official title | POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE. The ROADSTER 2 Study. |
| Lead sponsor | Silk Road Medical, Industry |
| Status | Completed |
| Study type | Observational [Patient Registry] |
| Conditions | Carotid Artery Disease |
| Enrollment | 692 |
| Start date | Oct 23, 2015 |
| Primary completion | Apr 29, 2019 |
| Completion | Apr 29, 2019 |
| First posted | Aug 31, 2015 |
| Last update posted | Jul 29, 2020 |
| Countries | Germany, Spain, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: